Overview
there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months
Description
this randomized clinical trial will include 152 patients of acute coronary syndrome with normal Vitamin D levels. they will be randomized to receive either Atorvastatin or Rosuvastatin. After 6 months of therapy, the impact on Vitamin D levels will be checked
Eligibility
Inclusion Criteria:
Acute Coronary Syndrome
25 OH-Vitamin D levels between 30-70ng/ml
Exclusion Criteria:
Hypercalcemia
hypocalcemia
pregnancy
lactation
hypersensitivity to statins
hypothyroidism
Deranged LFTs & RFTs
Use of following within last 3 months (Vitamin D Supplements, lipid lowering drugs, anti-obesity drugs, corticosteroids)